FDA approves Crystalens HD in quarter diopter steps

OSN Supersite


ALISO VIEJO, Calif. — Bausch & Lomb has received approval from the U.S. Food and Drug Administration to begin marketing its Crystalens HD in quarter diopter steps in the United States, the company announced in a press release.Bausch & Lomb will make the quarter diopter steps available for fourth-generation Crystalens models HD500 and HD520 in the ranges of 18 D to 22 D and expects to make a wider range of diopter steps available by the end of the year, the release said."Quarter diopter steps for the Crystalens 5-0 have been enthusiastically accepted by surgeons, so we have now added them to the HD model. We still remain the only presbyopic channel lenses available in the U.S. in quarter diopter steps," Mike Judy, vice president of global surgical marketing for Bausch & Lomb, said in the release.Bausch & Lomb will begin shipping the Crystalens HD in quarter diopter steps on July 16